2023. A Clinical Case of Successful Treatment of HER2-Low Disseminated Breast Cancer with Trastuzumab Deruxtecan. Voprosy onkologii. 69, 4 (Sep. 2023), 757–760. DOI:https://doi.org/10.37469/0507-3758-2023-69-4-757-760.